日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ASS1 inhibits liver cancer by promoting CAD ubiquitination and reversing the urea cycle and pyrimidine synthesis imbalance.

ASS1 通过促进 CAD 泛素化和逆转尿素循环和嘧啶合成失衡来抑制肝癌

Ming Zhengnan, Luo Tiao, Zou Zizheng, Luo Wensong, Hu Xiyuan, Chen Ling, Zhou Jiang, Liu Xiaohe, Liu Mingquan, Li Jijia, Luo Junli, Ma Dayou, Liu Suyou, Luo Zhiyong

LM2I leads to CAD ubiquitination and liver cancer suppression through activation of ASS1.

LM2I 通过激活 ASS1 导致 CAD 泛素化和肝癌抑制。

Ming Zhengnan, Luo Tiao, Zou Zizheng, Luo Wensong, Hu Xiyuan, Chen Ling, Zhou Jiang, Liu Xiaohe, Liu Mingquan, Li Jijia, Ma Dayou, Liu Suyou, Luo Zhiyong

Engineering Versatile Bacteria-Derived Outer Membrane Vesicles: An Adaptable Platform for Advancing Cancer Immunotherapy

构建多功能细菌来源外膜囊泡:一种用于推进癌症免疫疗法的适应性平台

Luo, Ziheng; Cheng, Xiang; Feng, Bin; Fan, Duoyang; Liu, Xiaohui; Xie, Ruyan; Luo, Ting; Wegner, Seraphine V; Ma, Dayou; Chen, Fei; Zeng, Wenbin